Literature DB >> 22845550

Analysis of Foxo1-regulated genes using Foxo1-deficient pancreatic β cells.

Satsuki Miyazaki1, Rie Minamida, Tatsuo Furuyama, Fumi Tashiro, Eiji Yamato, Shinobu Inagaki, Jun-ichi Miyazaki.   

Abstract

Several reports have suggested that Foxo1, a key regulator in differentiation, growth and metabolism, is involved in pancreatic β-cell function. However, detailed analyses have been hampered by a lack of Foxo1-deficient β cells. To elucidate Foxo1's function in β cells, we produced a β-cell line with inducible Foxo1 deletion. We generated a conditional knockout mouse line, in which Cre recombinase deletes the Foxo1 gene. We then established a β-cell line from an insulinoma induced in this knockout mouse by the β-cell-specific expression of simian virus 40 T antigen. In this cell line, designated MIN6-Foxo1flox/flox, adenovirus-mediated Cre expression ablates the Foxo1 gene, generating MIN6-Foxo1-KO cells. Using these knockout and floxed cell lines, we found that Foxo1 ablation enhanced the glucose-stimulated insulin secretion (GSIS) at high glucose concentrations and enhanced β-cell proliferation. We also conducted DNA microarray analyses of MIN6-Foxo1-KO cells infected with either an adenovirus vector expressing a constitutively active FOXO1 or a control vector and identified several Foxo1-regulated genes, including some known to be related to β-cell function. These cells should be useful for further studies on Foxo1's roles in β-cells and may lead to novel strategies for treating the impaired insulin secretion in type 2 diabetes mellitus.
© 2012 The Authors Journal compilation © 2012 by the Molecular Biology Society of Japan/Wiley Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22845550     DOI: 10.1111/j.1365-2443.2012.01625.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  5 in total

Review 1.  Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction.

Authors:  Shiying Shao; Yan Yang; Gang Yuan; Muxun Zhang; Xuefeng Yu
Journal:  DNA Cell Biol       Date:  2013-02       Impact factor: 3.311

2.  FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment.

Authors:  Arianna Smerieri; Luisa Montanini; Luigi Maiuri; Sergio Bernasconi; Maria E Street
Journal:  Int J Mol Sci       Date:  2014-10-08       Impact factor: 5.923

3.  IRE1-XBP1 pathway regulates oxidative proinsulin folding in pancreatic β cells.

Authors:  Yuichi Tsuchiya; Michiko Saito; Hiroshi Kadokura; Jun-Ichi Miyazaki; Fumi Tashiro; Yusuke Imagawa; Takao Iwawaki; Kenji Kohno
Journal:  J Cell Biol       Date:  2018-03-05       Impact factor: 10.539

4.  Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion.

Authors:  Satsuki Miyazaki; Fumi Tashiro; Takashi Tsuchiya; Kazuki Sasaki; Jun-Ichi Miyazaki
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes.

Authors:  Jayron J Habibe; Maria P Clemente-Olivo; Torsten P M Scheithauer; Elena Rampanelli; Hilde Herrema; Mariska Vos; Arnout Mieremet; Max Nieuwdorp; Daniel H van Raalte; Etto C Eringa; Carlie J M de Vries
Journal:  Diabetologia       Date:  2022-07-08       Impact factor: 10.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.